Cases - Business

Many Fortune 100 companies have found it beneficial to provide their top executives with free

According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product

Financial Planning Services. These companies understand the necessity of providing key employ

; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug.

Examples of combination products may in

ees with the tools to manage what they have worked so hard to accumulate. Although most compa

lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together.

nies have support services that are available to their general employee population, the compre

here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe

hensive financial planning benefit is normally reserved for top executives. Clearly, these ex

d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations.

Combination pro

ecutives have achieved a level of personal and financial success that requires a heightened de

ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc

gree of financial sophistication and expertise. More importantly, these large corporations re

easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi

cognize that to retain and augment their most important capital, their management team, they n

nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically

ot only have to offer a competitive total compensation package that leads to the creation of w

and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ

ealth, but they also have to arrange for the management and preservation of that wealth.

Many

ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi

of these companies have retained financial firms such as Morgan Stanley and their Wealth Advi

ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it.

Following aspects would a

sors to assist their executives with that endeavor. Compensation Resources, Inc. recognizes t

dd to the challenges in developing combination products:

Which markets to tap where the combination products can do fairly well?
Which combination prod

hat its client base of emerging and middle market business leaders have a similar profile and

cts are meaningful and rational?
Which therapeutic categories to select?
Which Combinations can address unmet needs of the patients?
Do combin

requires the same, if not more, financial sophistication than these large corporate executives

tions increase the patient compliance?
What would be the developing cost?
How to tackle the risks encountered during combination product developmen

.

As a result, we at Compensation Resources, Inc. have retained Al Elghandour a Vice Presiden

t?

As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel

t/Financial Advisor with Morgan Stanley to provide Financial Planning Services to our client b

ping new procedures for reviewing their safety, efficacy and quality.

Professional from academic institutions, pharmaceutical industries, health care indust

ase. This service will be limited to business owners and executives and will be provided to o

y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products

ur clients free of charge.

Compensation Resources, Inc. strives to be your trusted advisor fo

.

As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de

r building your business and helping you attract, retain and motivate the human capital you de

elopment. They need to be wiser in analyzing the market trends and the regulatory requirements.

Companies that provide selfless information through particip

mand for your business. Call us to get more information, or to set up an appointment with Al.

tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products

HTTP = HTML link (for blogs, profiles,phorums):
<a href="http://www.cases.org.ua/article/1135/cases-Compensation-Resources--Inc-Partners-With-Morgan-Stanley.html">Compensation Resources - Inc. Partners With Morgan Stanley</a>

BB link (for phorums):
[url=http://www.cases.org.ua/article/1135/cases-Compensation-Resources--Inc-Partners-With-Morgan-Stanley.html]Compensation Resources - Inc. Partners With Morgan Stanley[/url]

Choosing the topic of your ezine is no light decision. Here are 3 hints to help get you going in the right direction.

THE 8 ASCENTS OF THE ULTIMATE LEADER are the Psychological foundations of what makes a great Leader...

You should never forget to celebrate Secretaries Day. This day commemorates all the hard work your office assistant and many others around the world have put in to keep you on time, organized and up-to-date on the job.

Tags

Links

Cases - Compensation Resources - Inc. Partners With Morgan Stanley

Related Articles: